Table 2.
Summary of meta-analyses
| Outcomes | Indices | N | Mean difference (95% of CI) | p | I2 (p) | Bias |
|---|---|---|---|---|---|---|
| Body Composition | BM | 12 | -0.90 (-1.80, -0.01) | 0.05 | 0% (0.98) | Egger: p = 0.30; Begg: p = 0.63 |
| BMI | 9 | -0.57 (-1.35, 0.20) | 0.15 | 0% (0.63) | Egger: p = 0.88; Begg: p = 0.47 | |
| LBM | 4 | 0.71 (-3.09, 4.52) | 0.71 | 0% (0.98) | Egger: p = 0.49; Begg: p = 1.00 | |
| FBM | 10 | -1.22 (-2.59, 0.15) | 0.08 | 0% (0.97) | Egger: p = 0.09; Begg: p = 0.37 | |
| WC | 5 | -0.52 (-3.95, 2.91) | 0.77 | 0% (0.99) | Egger: p = 0.52; Begg: p = 0.81 | |
| HC | 3 | -0.22 (-4.41, 3.89) | 0.92 | 0% (0.95) | Egger: p = 0.59; Begg: p = 1.00 | |
| WHR | 2 | -0.00 (-0.05, 0.04) | 0.85 | 0% (0.82) | ||
| Metabolism | TC | 8 | -1.51 (-9.82, 6.80) | 0.72 | 0.5% (0.43) | Egger: p = 0.43; Begg: p = 0.90 |
| TG | 9 | -10.78 (-20.68, -0.88) | < 0.05 | 0% (0.53) | Egger: p = 0.98; Begg: p = 0.75 | |
| HDL-C | 11 | -1.72 (-6.17, 2.73) | 0.45 | 44% (0.06) | Egger: p = 0.84; Begg: p = 0.36 | |
| LDL-C | 10 | -3.74 (-6.92, -0.56) | < 0.05 | 0% (0.77) | Egger: p = 0.11; Begg: p = 0.22 | |
| Glucose | 3 | -1.74 (-16.24, 12.76) | 0.81 | 0% (0.97) | Egger: p = 0.31; Begg: p = 1.00 | |
| Insulin | 5 | 0.62 (-1.66, 2.89) | 0.60 | 0% (0.49) | Egger: p = 0.70; Begg: p = 1.00 | |
| HOMA-IR | 5 | -0.22 (-0.33, -0.11) | < 0.05 | 0% (0.50) | Egger: p = 0.40; Begg: p = 0.81 |
BM: body mass; BMI: body mass index; CI: confidence interval; LBM: lean body mass; FBM: fat body mass; WC: waist circumference; HC: hip circumference; WHR: waist-to-hip ratio; TC: total cholesterol; TG: triglyceride; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; HOMA-IR: homeostasis model assessment of insulin resistance. Bold text signifes statistically significant results